Loading clinical trials...
Loading clinical trials...
A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
Conditions
Interventions
Subjects who receive the Treovance stent-graft
Locations
29
United States
University of Alabama-Birmingham
Birmingham, Alabama, United States
Arizona Heart Institute
Phoenix, Arizona, United States
Danbury Hospital
Danbury, Connecticut, United States
Lynn Heart and Vascular Institute
Boca Raton, Florida, United States
Northside Hospital Heart & Vascular Institute
Atlanta, Georgia, United States
Presence Medical Center -- Christie Clinic
Champaign, Illinois, United States
Start Date
November 23, 2013
Primary Completion Date
March 20, 2017
Completion Date
June 1, 2026
Last Updated
January 28, 2026
NCT06586021
NCT01726257
NCT04592991
NCT01990950
NCT03231397
NCT02007252
Lead Sponsor
Bolton Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions